Erythromelagia: a rare and hard-to-treat condition: a 9-year-old boy responsive to intravenous lidocaine and oral mexilitene.
Francisca
F
Elgueta
Juan Carlos
JC
de la Cuadra-Fontaine
Leticia
L
Clede
Claudio
C
Fierro
Antonia
A
Valderrama
D061605:Administration, Intravenous; D000284:Administration, Oral; D002648:Child; D004916:Erythromelalgia / Q000188:drug therapy*; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use*; D008297:Male; D008801:Mexiletine / Q000627:therapeutic use*; D061567:Voltage-Gated Sodium Channel Blockers / Q000627:therapeutic use*
D061567:Voltage-Gated Sodium Channel Blockers; D008801:Mexiletine; D008012:Lidocaine